AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04472949 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Thoracic radiotherapy
Description: Thoracic radiotherapy: 39 Gy in 13 fractions, starting 3-8 weeks after day 1 of last cycle of induction treatment, over 2.5 weeks Prophylactic cranial irradiation (PCI) is allowed but optional: according to local practice, starting 3-8 weeks after day 1 of last cycle of induction treatment Follow up phase Patients will be followed up for 24 months, every 8 weeks.
Study NCT06513169 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Group 1: LEE
Description: Patients will be in supine position during induction with a 12 wedge placed at the level of the Achilles tendon (LEE)
Study NCT06465433 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tafasitamab
Description: Treatment with tafasitamab is as per the treatment dose and schedule they received in the parent protocols.
Study NCT05551858 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Proglumide
Description: (CAS: 6620-60-6.)
Study NCT05551858 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Avicel fiber filled capsule taken by mouth three times daily
Study NCT04827446 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Wearable Sensor
Description: Patient is given a wearable device to wear for 12 weeks.
Study NCT04827446 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Wearable Sensor
Description: Patient is given a wearable device to wear for 12 weeks.
Study NCT04827446 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blue-blocking glasses
Description: Patient is given blue-blocking glasses to wear at instructed times.
Study NCT04827446 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Clear glasses
Description: Patient is given glasses that block no visible light.
Study NCT04827446 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Full SYNC app
Description: Patient downloads the SYNC app and is given light interventions designed to have a targeted, personalized effect on the circadian clock.
Study NCT04827446 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dummy SYNC app
Description: Patient downloads the SYNC app and is given light interventions designed to have minimal impact on the circadian clock.
Study NCT04931875 — intervention group
Intervention type: DEVICE
Intervention: Total body PET/CT (uExplorer)
Description: A total-body PET/CT scanner (uEXPLORER) with a 194-cm scan range will be applied in patients affected with lymphoma.
Study NCT05178199 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: RPSG
Description: The RPSG program include sharing successful experience, progressive muscle relaxation (PMR), and mindfulness-based stress reduction (MBSR). The duration is at last 8 weeks and includes 1 hour per week of RPSG activities.
Study NCT05178199 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: RPSG
Description: The RPSG program include sharing successful experience, progressive muscle relaxation (PMR), and mindfulness-based stress reduction (MBSR). The duration is at last 8 weeks and includes 1 hour per week of RPSG activities.
Study NCT05178199 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: AVMBM
Description: The duration is also at last 8 weeks and includes encouraging to use 5 minutes Audio and Video Mindfulness of Breathing Meditation (AVMBM) per week.
Study NCT05178199 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AVMBM
Description: The duration is also at last 8 weeks and includes encouraging to use 5 minutes Audio and Video Mindfulness of Breathing Meditation (AVMBM) per week.
Study NCT05874284 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gelofusin
Description: In the experimental group, the wound will be washed with gelofusine as prolotherapy, and the wound will be closed with sterile sponge and fixative tape. In the control group, the wound will be covered with sterile sponge and fixative tape by washing with physiological saline.
Study NCT06008392 — intervention group
Intervention type: GENETIC
Intervention: Pan-genomic Testing
Description: Participants will be scheduled to review the study specifics, review consent and gather medical information. Once consented, samples will be collected. When the samples are received by Exact Sciences, DNA and RNA will be extracted, and sequencing will be performed. Following pan-genomic testing, participants will receive the full report with results from their care team and results will also be added to the patient's portal. If a germline finding is identified (positive pathogenic variant) the participant will also be referred for a genetic counselor visit. All results from the germline hereditary test will be reviewed by a certified genetic counselor in addition to a review of their pedigree. To help with review of any genetic research findings, the study team may request to obtain genomic data from previous genetic testing (clinical or research based).
Study NCT05392309 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Manual ankle rocking training
Description: Group will receive manual ankle rocking training with lower limb exercise and core strengthening of trunk
Study NCT05392309 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional
Description: Group will receive lower limb exercises and core strengthening of trunk. Sessions will be 4 days in a week
Study NCT05392309 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional
Description: Group will receive lower limb exercises and core strengthening of trunk. Sessions will be 4 days in a week
Study NCT04653285 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: motor skill practice
Description: Motor learning task on a stability platform (stabilometer). Participants try to keep the tiltable platform in a horizontal position in trials of 30s.
Study NCT04653285 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: motor skill practice
Description: Motor learning task on a stability platform (stabilometer). Participants try to keep the tiltable platform in a horizontal position in trials of 30s.
Study NCT04653285 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: aerobic exercise
Description: A bout of moderate intensity aerobic exercise on a cycle ergometer following motor skill practice.
Study NCT04653285 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: rest
Description: Seated rest following motor skill practice.
Study NCT05734755 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Individualized Dietary Behavioural Change Programme (IDBC)
Description: The first three weekly face-to-face sessions will be during the 'goal initiation' and 'planning' phases. The remaining seven face-to-face sessions will be offered once to twice per month between weeks 4 and 24 during the program at the 'action execution' phase. Family members will be encouraged to join the dietary consultations. Strategies will be discussed with the family members to facilitate the participant's adherence to the recommended diet regimen.Phase I Goal Initiation is aimed at motivating the participants to actively manage their sarcopenic obesity. Phase II Plan Formulation is aimed at guiding the participants in transforming their (sub-) goals into detailed individualized action plans.Phase III Action Execution is aimed at encouraging the participants to continually execute the action plan. The IDBC guidebook will be given to the participants to guide them on how to gradually adopt our dietary recommendations in their daily life.
Study NCT05734755 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Exercise Training
Description: The group size will be \< 10. They will be used in the resistance exercise in this study to improve muscle strength (20 mins). Brisk walking (20 mins) will be employed in the aerobic exercise in this study. Each session will include 10 minutes of warm-up and cool-down exercises at the beginning and at the end. A YouTube video and a pamphlet describing the different types of exercises used in this programme will be disseminated to all participants to encourage them to continually practise their exercises at home for 30 minutes at least 5 times per week.
Study NCT06396819 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: collagen-povidone solution
Description: Application of collagen-povidone solution at a dose of 0.2 cc, compared with the application of physiological solution in the control group
Study NCT06396819 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: collagen-povidone solution
Description: Application of collagen-povidone solution at a dose of 0.2 cc, compared with the application of physiological solution in the control group
Study NCT06048484 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Quemliclustat
Description: 100 mg IV
Study NCT04883866 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telephone Breastfeeding Support Program
Description: On the 3rd day after discharge, a reminder messages will be sent to the mothers in the inter vention group. Throughout the program, 21 reminder messages will be sent to mothers in the first month after discharge to support the mother and encourage breast milk via a messaging application (whatsapp, bip, telegram, etc.). In addition, a total of seven phone calls, once a week in the first month after discharge and once a month in the eighth, twelfth and sixteenth weeks, will be made to check personalized information about individual breastfeeding questions of mothers.
Study NCT04883866 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sending a breastfeeding guide for premature babies to the phone of mothers in addition to the routine discharge procedure
Description: In addition to the routine discharge procedure, a breastfeeding guide for premature babies will be sent to the mothers' phone.
Study NCT05912764 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Patient support
Description: Patients will be supported by nurses before and after intervention and hospital leave
Study NCT04707495 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Smartphone Application (SPSRS)
Description: The experimental group receives video-viewing intervention using the SPSRS application, which is a smartphone application. SPSRS is programmed to present 150 ms of positive words after presenting 17 ms of self-confidence-boosting words in videos.~These words are repeated every 5 s. The words to increase self-confidence are can, let us try, good luck, able, and do not worry. These self-confidence-boosting words randomly appear in the four corners of the screen. The positive words are nice, great, fantastic, satisfactory, and enjoyable. These words are displayed at the center of the screen. Interveners use the SPSRS application according to the operating manual. The participants will use an iPhone managed by interveners to watch a pre-determined 10-minute video.
Study NCT04707495 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Smartphone Application (YouTube)
Description: The control group uses the same iPhone as the experimental group. The control group uses the YouTube application to receive video-viewing intervention. The control group videos do not show confidence-boosting and positive words. The control group watches the same video as the experimental group for 10 min.
Study NCT06048484 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etrumadenant
Description: 150 mg orally
Study NCT05913830 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Auricular pressure
Description: The seeds of blancia blanc were fixed on the acupoints with patches. The intervention measure in the experimental group was auricular point sticking. The two groups received four measurements before the intervention and 2 weeks, 4 weeks, and 6 weeks after the start; while the control group received no Auricular pressure.
Study NCT04824469 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: intervention group
Description: web based training: By establishing a website, training on drug use, symptom management and quality of life will be provided.
Study NCT06048484 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Modified FOLFIRINOX
Description: * Oxaliplatin 85 mg per square meter IV~* Irinotecan 150 mg per square meter IV~* Leucovorin 400 mg per square meter IV~* Fluorouracil 2400 mg per square meter IV~* Pegfilgrastim injector kit (6mg subcutaneous)
Study NCT06048484 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Modified FOLFIRINOX
Description: * Oxaliplatin 85 mg per square meter IV~* Irinotecan 150 mg per square meter IV~* Leucovorin 400 mg per square meter IV~* Fluorouracil 2400 mg per square meter IV~* Pegfilgrastim injector kit (6mg subcutaneous)
Study NCT05298124 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcatheter edge-to-edge repair
Description: Transcatheter edge-to-edge repair
Study NCT05202678 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: AGN1 LOEP
Description: Subjects with osteoporosis are treated with AGN1 local osteo-enhancement procedure in the proximal femur
Study NCT05180383 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobile Application to Prevent Suicide (MAPS)
Description: Safety Planning Intervention, ecological momentary intervention smartphone app system, and bidirectional communication with study clinician.
Study NCT05298124 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Medical therapy
Description: Medical treatment in an intensive care unit
Study NCT05104307 — intervention group
Intervention type: DEVICE
Intervention: Cardiac Performance System (CPS) Device
Description: CPS is a passive measurement system that acquires signals from multiple sensor sources that monitor cardiac heart sounds. The passive sensor systems measure sound only and do not produce energy. The CPS system also includes a Patient Monitor device that acquires data from the sensors as well as from three standard ECG electrodes. The CPS system does not acquire or store any protected health information or any subject characteristics. The CPS system has received FDA clearance K173156. Note that the CPS system was previously named Integrated CardioRespiratory (ICR) system. The CPS is FDA cleared for the ejection fraction (EF) assessment which will be its intended use for this study.
Study NCT05701007 — intervention group
Intervention type: DRUG
Intervention: abiraterone
Description: mCRPC
Study NCT05701007 — intervention group
Intervention type: DRUG
Intervention: enzalutamide
Description: mCRPC
Study NCT05701007 — intervention group
Intervention type: DRUG
Intervention: docetaxel
Description: mCRPC
Study NCT05701007 — intervention group
Intervention type: DRUG
Intervention: apalutamide
Description: mCRPC
Study NCT05701007 — intervention group
Intervention type: DRUG
Intervention: cabazitaxel
Description: mCRPC
Study NCT05701007 — intervention group
Intervention type: DRUG
Intervention: Radium-223
Description: mCRPC
Study NCT05701007 — intervention group
Intervention type: DRUG
Intervention: Lutetium-177
Description: mCRPC
Study NCT05701007 — intervention group
Intervention type: DRUG
Intervention: degarelix
Description: mCSPC
Study NCT05701007 — intervention group
Intervention type: DRUG
Intervention: goserelin
Description: mCSPC
Study NCT05701007 — intervention group
Intervention type: DRUG
Intervention: leuprorelin
Description: mCSPC
Study NCT05701007 — intervention group
Intervention type: DRUG
Intervention: triptorelin
Description: mCSPC
Study NCT05460611 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sciton HALO 1470nm Non-ablative laser
Description: Patients will be treated with the 1470nm non-ablative laser.
Study NCT05309317 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Simulation Game for the Prevention of Catheter-Associated Urinary Tract Infections
Description: A training on Prevention of CAUTI will be held for the experimental and control groups. The experimental group will be able to play a seven-day virtual simulation game devised by the researcher to prevent CAUTI.
Study NCT05309317 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ongoing education
Description: Only a course on Prevention of CAUTI will be given to the control group.
Study NCT05309317 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ongoing education
Description: Only a course on Prevention of CAUTI will be given to the control group.
Study NCT04791410 — intervention group
Intervention type: PROCEDURE
Intervention: microvascular decompression
Description: Microvascular decompression of rostral ventrolateral medulla
Study NCT04342390 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Description: The exercise we are studying is called high-intensity interval training, or HIIT. Participants in the exercise group will participate in the exercise program. Each exercise session will last up to 1 hour. All exercise sessions will be directed and monitored by an experienced exercise trainer or exercise physiologist.
Study NCT06006650 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin
Description: Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin
Study NCT06006650 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin
Description: Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin
Study NCT05616923 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trametinib
Description: Topical cream containing 0.1 mg/g trametinib
Study NCT05616923 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Trametinib
Description: Topical cream containing 0.1 mg/g trametinib
Study NCT05851196 — intervention group
Intervention type: OTHER
Intervention: Proprioceptive training
Description: A physiotherapist tailors the exercises to the patient's functional demands and pain- or fear-inducing activities. Guided by the therapist, patients look for ways to integrate the exercises into their daily life activities. Each week, patients receive feedback from the physiotherapist, and the training program is gradually progressed. The patients are instructed to perform the exercises daily, integrated into their daily activities, hobbies, and work. The program contains: (1) exercises to improve the sense of posture and movement, (2) exercises to correct the reference frame from which patients control posture and movement, (3) muscle control exercises, (4) exercises to increase variability in postures and movement patterns, (5) functionality: patients search for ways to correct and integrate alternative postures and movement patterns into their daily life, (6) high training frequency and high load, (7) focus on sensing, localizing and differentiating, rather than movement control.
Study NCT05754723 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: e-Psychotherapy/Psychoeducation
Description: Participants will receive six weekly self-guided psychoeducation sessions. Then, after 6 weeks participants will complete monthly clinical questionnaires for 6 months. Also, participants will begin bi-weekly journaling exercises for 6 months. Based on the journaling entries, if the AI algorithm detects MDD, GAD, SAD or ADHD that requires treatment will make a referral to the diagnosis-specific e-CBT (MDD, GAD, SAD or ADHD). If after 6 months, no referral decision is made by the AI algorithm no extra follow-up will be provided. Once the AI makes a referral recommendation, participants will be placed in a diagnosis-specific e-CBT program specific to the diagnosis determined by the AI algorithm (MDD, GAD, SAD, or ADHD). The asynchronous e-CBT programs will consist of 12 weekly modules and homework. Weekly homework is reviewed by a therapist, who will provide personalized feedback based on the participant's preferred method (i.e., text, video, or audio).
Study NCT05440812 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Storytelling and Training to Advance Individual Recovery Skills (STAIRS)
Description: STAIRS is a 8-week program, in which 8 different themes are addressed. Coverage of each theme starts with a group meeting guided by a professional and expert by experience. In these meetings different exercises are done (e.g., filling out an actual and desired week-schedule, role-playing a difficult situation), information is given and experiences are shared. Between meetings, participants can choose from a range of homework exercises to practice their desired skills in a tailored way. In addition, participants can share experiences with the other group members and exchange reactions using a private online community.
Study NCT04792021 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: N-acetylcysteine
Description: Oral formulation: 600 mg sachets of N-acetylcysteine
Study NCT06192849 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furmonertinib
Description: This arm plans to enroll 20 subjects, treating with furmonertinib 160mg/d, until disease recurrence, death or intolerability. The maximum duration of treatment is three years.
Study NCT05371925 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sulodexide
Description: one 250LRU sulodexide capsule twice a day for 8 weeks
Study NCT05371925 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sulodexide
Description: one 250LRU sulodexide capsule twice a day for 8 weeks
Study NCT05577923 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trastuzumab
Description: 8 mg/kg loading dose IV, then 6 mg/kg IV, every 3 weeks
Study NCT05577923 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pyrotinib
Description: Pyrotinib 320mg, PO daily, continuously
Study NCT05577923 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dalpiciclib
Description: Dalpiciclib will be given at the dose of 125 mg po q.d. x 21 every 4 weeks
Study NCT05577923 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: fulvestrant
Description: Fulvestrant will be given intramuscle at the dose of 500 mg every 4 weeks (with an additional 500 mg dose given two weeks after the initial dose.